Aclaris Therapeutics, Inc. (ACRS): Price and Financial Metrics
ACRS Price/Volume Stats
| Current price | $1.57 | 52-week high | $5.17 |
| Prev. close | $1.59 | 52-week low | $1.05 |
| Day low | $1.54 | Volume | 589,500 |
| Day high | $1.61 | Avg. volume | 920,875 |
| 50-day MA | $1.41 | Dividend yield | N/A |
| 200-day MA | $1.95 | Market Cap | 170.00M |
ACRS Stock Price Chart Interactive Chart >
Aclaris Therapeutics, Inc. (ACRS) Company Bio
Aclaris Therapeutics, Inc. is a clinical-stage specialty pharmaceutical company focused on identifying, developing, and commercializing novel drugs to address unmet needs in dermatology. The company was founded in 2012 and is based in Malvern, Pennsylvania.
ACRS Price Returns
| 1-mo | 6.80% |
| 3-mo | 33.05% |
| 6-mo | -37.20% |
| 1-year | 18.94% |
| 3-year | -89.68% |
| 5-year | -21.50% |
| YTD | -36.69% |
| 2024 | 136.19% |
| 2023 | -93.33% |
| 2022 | 8.32% |
| 2021 | 124.73% |
| 2020 | 242.33% |
Continue Researching ACRS
Want to see what other sources are saying about Aclaris Therapeutics Inc's financials and stock price? Try the links below:Aclaris Therapeutics Inc (ACRS) Stock Price | Nasdaq
Aclaris Therapeutics Inc (ACRS) Stock Quote, History and News - Yahoo Finance
Aclaris Therapeutics Inc (ACRS) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...